Institutional investors control 10.12% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended September 2017, these large investors purchased a net $13.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 14.8 Million shares of GlaxoSmithKline
T. ROWE PRICE ASSOCIATES, INC. Bought 3.3 Million shares of GlaxoSmithKline
MANAGED ACCOUNT ADVISORS LLC Bought 2.1 Million shares of GlaxoSmithKline